Table 1

Study population, cases and incidence rates of valvular heart disease in Sweden between 2003 and 2010

Men (n=5 060 355)Women (n=5 103 856)
PopulationNAge, yearsIQRIR95% CINAge, yearsIQRIR95% CI
Any VHD345827058–7975.574.7 to 76.3312217664–8353.052.5 to 53.6
Subtypes
 Aortic stenosis188907464–8137.837.3 to 38.3174298072–8524.223.8 to 24.5
 Aortic regurgitation83766343–7320.219.7 to 20.654777157–7910.810.6 to 11.1
 Mitral stenosis 6356445–76 1.5 1.4 to 1.612827458–81 2.3 2.2 to 2.5
 Mitral regurgitation97796959–7721.320.9 to 21.788167461–8116.015.7 to 16.4
 Pulmonary stenosis1109 6 0–20 3.7 3.5 to 4.01351 4 0–22 4.8 4.5 to 5.0
 Pulmonary regurgitation 34416 8–33 1.0 0.9 to 1.2 29319 8–42 0.9 0.8 to 1.0
 Tricuspid stenosis 15149 5–72 0.4 0.4 to 0.5 1516215–76 0.4 0.3 to 0.4
 Tricuspid regurgitation11927362–80 2.5 2.3 to 2.616937565–82 2.8 2.7 to 3.0
Two concurrent VHD3656 8.5 8.2 to 8.83206 5.8 5.6 to 6.0
Three or more concurrent VHD 279 0.7 0.6 to 0.8 291 0.3 0.3 to 0.3
  • Incidence rate (IR) per 1 00 000 person-years at risk between 2003 and 2010 in the Swedish population with 95% CIs. A 3-year washout period was used between 2000 and 2002 to only include incident cases. Age is presented as median age at diagnosis and interquartile range (IQR). VHD, valvular heart disease.